Taking Eketinib Hydrochloride Tablets for diarrhea is mainly caused by the side effects of the drug, and the treatment mainly includes stopping the drug, replacing the drug, and symptomatic treatment.
Ectinib hydrochloride belongs to antitumor drugs, mainly used for locally advanced or metastatic non-small cell lung cancer. The percentage of diarrhea adverse reactions occurred in phase III clinical trials and post-marketing phase IV clinical trials were 11.8% and 9.1%, respectively.
1. For oral Ectinib Hydrochloride Tablets with mild diarrhea, if it does not affect the patient’s normal life, it can be left untreated and continue to be taken.
2. For oral Eketinib Hydrochloride Tablets diarrhea is more serious, the patient can not tolerate, under the guidance of the doctor can be suspended until the symptoms are relieved or disappeared, and then continue to take, or under the guidance of the doctor to replace other drugs.
3. If necessary, symptomatic antidiarrheal treatment can be taken, such as giving montelukast and other drugs.
The above medication or adjustment of medication should be used under the guidance of a doctor to avoid self-medication.